BDL
AZN icon

Banque de Luxembourg’s AstraZeneca AZN Stock Holding History

Banque de Luxembourg’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
5,968
+640
+12% +$120K 0.53% 29
2026
Q1 		$1.04M Buy
+5,328
New +$1.03M 0.54% 28

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Banque de Luxembourg's AZN Position: Q2 2026 in Review

Banque de Luxembourg increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $120K and bringing the position to 5,968 shares worth $1.13M. The position accounts for 0.53% of the portfolio, ranked #29.

Banque de Luxembourg first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Banque de Luxembourg held 5,968 shares of AstraZeneca worth $1.13M as of Q2 2026.
  • Banque de Luxembourg bought 640 AstraZeneca shares in Q2 2026, an estimated $120K.
  • AstraZeneca made up 0.53% of Banque de Luxembourg's portfolio in Q2 2026, its #29 holding.
  • Banque de Luxembourg first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Banque de Luxembourg's 13F filing for Q2 2026, filed 9 Jul 2026.